{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:24:01Z","timestamp":1787747041255,"version":"build-2784847793"},"reference-count":83,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Lithium remains a mainstay of therapy for bipolar disease and refractory depression, with future potential for expanded use on the basis of novel data demonstrating its immunomodulatory and neuroprotective effects. This drug accumulates intracellularly\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      sodium transport pathways, and its effects on complex cellular signaling mechanisms, including glycogen synthase kinase-3\n                      <jats:italic toggle=\"yes\">\u03b2<\/jats:italic>\n                      inhibition, form the basis of its therapeutic efficacy and toxicity. Increased intracellular levels disrupt cellular processes and trigger injury\n                      <jats:italic toggle=\"yes\">via<\/jats:italic>\n                      mitochondrial dysfunction and oxidative stress. Lithium has a narrow therapeutic index and causes dose-dependent nephrotoxicity. A tubulointerstitial pattern of kidney injury is typical; however, lithium can rarely cause glomerular injury as well. An acute rise in serum lithium levels can result in severe volume depletion from lithium-induced natriuresis and aquaresis and cause AKI. Changes in kidney function and various drug interactions can acutely affect serum lithium levels, further increasing the risk of toxicity. Arginine vasopressin resistance is the most common complication of chronic lithium use and can be an early manifestation. CKD occurs after a longer latency of over 10 years with a variable slope of GFR decline. Progression to kidney failure is relatively low but is affected by the presence of other nephrotoxic risk factors. Epithelial sodium channel blockers such as amiloride can be helpful in mitigating lithium nephrotoxicity by reducing cellular accumulation. Hypercalcemia secondary to lithium-induced hyperparathyroidism is associated with a higher risk of nephrolithiasis and CKD progression. Kidney microcystic changes are common in lithium-induced CKD, and distal renal tubular acidosis can also be seen. Using the lowest effective lithium dose, close monitoring of kidney function and serum lithium levels and early diagnosis of lithium nephrotoxicity is critical in preventing irreversible kidney injury. The decision to discontinue lithium is challenging, and the benefits versus risks must be carefully weighed. This comprehensive review provides a pathogenetic basis and practical clinical framework for diagnosis and management of lithium nephrotoxicity.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1681\/asn.0000001172","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:02:05Z","timestamp":1780675325000},"page":"1789-1801","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and Management of Acute and Chronic Lithium-Associated Nephrotoxicity"],"prefix":"10.1681","volume":"37","author":[{"given":"Namrata","family":"Krishnan","sequence":"first","affiliation":[{"name":"Section of Nephrology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut"},{"name":"Section of Nephrology, Department of Medicine, Veterans Administration, West Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6994-2659","authenticated-orcid":false,"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Medicine, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"issue":"1","key":"B1-20260826","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40345-019-0151-2","article-title":"Clinical use of lithium salts: guide for users and prescribers","volume":"7","author":"Tondo","year":"2019","journal-title":"Int J Bipolar Disord."},{"issue":"1","key":"B2-20260826","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s40345-024-00362-7","article-title":"Lithium: current state of the art and future directions","volume":"12","author":"Gitlin","year":"2024","journal-title":"Int J Bipolar Disord."},{"issue":"5-6","key":"B3-20260826","first-page":"205","article-title":"Lithium: fifteen years later","volume":"83","author":"Rybakowski","year":"2024","journal-title":"Neuropsychobiology."},{"issue":"4","key":"B4-20260826","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/ph18040467","article-title":"The mechanisms of lithium action: the old and new findings","volume":"18","author":"Sakrajda","year":"2025","journal-title":"Pharmaceuticals (Basel)."},{"issue":"10","key":"B5-20260826","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(22)00308-X","article-title":"Lithium: balancing mental and renal health","volume":"9","author":"Strawbridge","year":"2022","journal-title":"Lancet Psychiatry."},{"issue":"1","key":"B6-20260826","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12882-018-1101-4","article-title":"Lithium and nephrotoxicity: a literature review of approaches to clinical management and risk stratification","volume":"19","author":"Davis","year":"2018","journal-title":"BMC Nephrol."},{"issue":"3","key":"B7-20260826","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1681\/ASN.V103666","article-title":"Lithium intoxication","volume":"10","author":"Timmer","year":"1999","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B8-20260826","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/gps.1961","article-title":"Renal effects of long-term lithium therapy in the elderly: a cross-sectional study","volume":"23","author":"van Melick","year":"2008","journal-title":"Int J Geriatr Psychiatry."},{"issue":"2","key":"B9-20260826","doi-asserted-by":"crossref","first-page":"e70082","DOI":"10.1111\/bdi.70082","article-title":"A significant decline of glomerular filtration rate in the majority of long-term lithium users: results of a Dutch prospective 10-year cohort study","volume":"28","author":"van der Aa","year":"2026","journal-title":"Bipolar Disord."},{"issue":"5","key":"B10-20260826","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0272-6386(96)90108-0","article-title":"Nephrotic syndrome and renal insufficiency associated with lithium therapy","volume":"27","author":"Tam","year":"1996","journal-title":"Am J Kidney Dis."},{"issue":"5","key":"B11-20260826","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.ekir.2024.01.047","article-title":"Lithium-associated kidney failure: predictors and outcomes","volume":"9","author":"Qian","year":"2024","journal-title":"Kidney Int Rep."},{"key":"B12-20260826","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ejphar.2014.06.042","article-title":"Lithium: a review of pharmacology, clinical uses, and toxicity","volume":"740","author":"Oruch","year":"2014","journal-title":"Eur J Pharmacol."},{"issue":"9817","key":"B13-20260826","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(11)61516-X","article-title":"Lithium toxicity profile: a systematic review and meta-analysis","volume":"379","author":"McKnight","year":"2012","journal-title":"Lancet."},{"issue":"5","key":"B14-20260826","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nrneph.2009.43","article-title":"Lithium nephrotoxicity revisited","volume":"5","author":"Gr\u00fcnfeld","year":"2009","journal-title":"Nat Rev Nephrol."},{"issue":"5","key":"B15-20260826","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bdi.12805","article-title":"What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD\/IGSLI task force on treatment with lithium","volume":"21","author":"Nolen","year":"2019","journal-title":"Bipolar Disord."},{"issue":"7","key":"B16-20260826","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1073\/pnas.74.7.3099","article-title":"Lithium efflux through the Na\/K pump in human erythrocytes","volume":"74","author":"Dunham","year":"1977","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"4","key":"B17-20260826","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/ndt\/gfk029","article-title":"A hypothesis linking sodium and lithium reabsorption in the distal nephron","volume":"21","author":"Thomsen","year":"2006","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B18-20260826","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1681\/ASN.2015080907","article-title":"Lithium in the kidney: friend and foe?","volume":"27","author":"Alsady","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B19-20260826","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1021\/acs.molpharmaceut.8b00018","article-title":"Sodium transporters are involved in lithium influx in brain endothelial cells","volume":"15","author":"Luo","year":"2018","journal-title":"Mol Pharm."},{"issue":"6","key":"B20-20260826","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1053\/j.ajkd.2021.06.030","article-title":"The role of the nephrologist in management of poisoning and intoxication: core curriculum 2022","volume":"79","author":"Mullins","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B21-20260826","doi-asserted-by":"crossref","first-page":"e2322056","DOI":"10.1001\/jamanetworkopen.2023.22056","article-title":"Absolute and relative risks of kidney outcomes associated with lithium vs valproate use in Sweden","volume":"6","author":"Bosi","year":"2023","journal-title":"JAMA Netw Open."},{"issue":"5","key":"B22-20260826","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2215\/CJN.10021014","article-title":"Extracorporeal treatment for lithium poisoning: systematic review and recommendations from the EXTRIP workgroup","volume":"10","author":"Decker","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"6","key":"B23-20260826","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11102-022-01276-2","article-title":"Changing the name of diabetes insipidus","volume":"25","author":"Arima","year":"2022","journal-title":"Pituitary."},{"issue":"1","key":"B24-20260826","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int J Bipolar Disord."},{"issue":"1","key":"B25-20260826","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40345-023-00286-8","article-title":"Long-term lithium therapy and risk of chronic kidney disease, hyperparathyroidism and hypercalcemia: a cohort study","volume":"11","author":"Boivin","year":"2023","journal-title":"Int J Bipolar Disord."},{"issue":"8","key":"B26-20260826","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40262-016-0370-y","article-title":"Drug interactions with lithium: an update","volume":"55","author":"Finley","year":"2016","journal-title":"Clin Pharmacokinet."},{"key":"B27-20260826","doi-asserted-by":"crossref","first-page":"138343","DOI":"10.1016\/j.jhazmat.2025.138343","article-title":"A reversible fluorescence probe enables bioimaging and toxicity evaluation of lithium ion in living human cells","volume":"493","author":"Gong","year":"2025","journal-title":"J Hazard Mater."},{"issue":"5","key":"B28-20260826","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1007\/s12011-020-02302-9","article-title":"In vitro and in vivo evidence on the role of mitochondrial impairment as a mechanism of lithium-induced nephrotoxicity","volume":"199","author":"Ommati","year":"2021","journal-title":"Biol Trace Elem Res."},{"issue":"2","key":"B29-20260826","doi-asserted-by":"crossref","first-page":"e2458608","DOI":"10.1001\/jamanetworkopen.2024.58608","article-title":"Lithium for bipolar disorder and risk of thyroid dysfunction and chronic kidney disease","volume":"8","author":"Chan","year":"2025","journal-title":"JAMA Netw Open."},{"issue":"6","key":"B30-20260826","doi-asserted-by":"crossref","first-page":"F1198","DOI":"10.1152\/ajprenal.00118.2003","article-title":"Segment-specific ENaC downregulation in kidney of rats with lithium-induced NDI","volume":"285","author":"Nielsen","year":"2003","journal-title":"Am J Physiol Renal Physiol."},{"issue":"5","key":"B31-20260826","doi-asserted-by":"crossref","first-page":"F1222","DOI":"10.1152\/ajprenal.00321.2005","article-title":"Lithium-induced NDI in rats is associated with loss of alpha-ENaC regulation by aldosterone in CCD","volume":"290","author":"Nielsen","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"issue":"12","key":"B32-20260826","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/jat.4167","article-title":"Lithium toxicity and the kidney with special focus on nephrotic syndrome associated with the acute kidney injury: a case-based systematic analysis","volume":"41","author":"\u0141ukawska","year":"2021","journal-title":"J Appl Toxicol."},{"issue":"4","key":"B33-20260826","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00467-001-0809-7","article-title":"Lithium-induced nephrotic syndrome in a young pediatric patient","volume":"17","author":"Sakarcan","year":"2002","journal-title":"Pediatr Nephrol."},{"issue":"1","key":"B34-20260826","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/0891988712436690","article-title":"The effects of lithium on renal function in older adults--a systematic review","volume":"25","author":"Rej","year":"2012","journal-title":"J Geriatr Psychiatry Neurol."},{"issue":"7","key":"B35-20260826","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ekir.2022.04.008","article-title":"Chronic lithium therapy and urine-concentrating ability in individuals with bipolar disorder: association between daily dose and resistance to vasopressin and polyuria","volume":"7","author":"Tabibzadeh","year":"2022","journal-title":"Kidney Int Rep."},{"key":"B36-20260826","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.euroneuro.2019.11.006","article-title":"Systematic review and practical guideline for the prevention and management of the renal side effects of lithium therapy","volume":"31","author":"Schoot","year":"2020","journal-title":"Eur Neuropsychopharmacol."},{"issue":"3","key":"B37-20260826","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1681\/ASN.2013090988","article-title":"Lithium causes G2 arrest of renal principal cells","volume":"25","author":"de Groot","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B38-20260826","doi-asserted-by":"crossref","first-page":"F39","DOI":"10.1152\/ajprenal.00383.2005","article-title":"Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct","volume":"291","author":"Christensen","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"issue":"suppl 16","key":"B39-20260826","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1093\/joneph\/23.S16.S43","article-title":"Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings","volume":"23","author":"Trepiccione","year":"2010","journal-title":"J Nephrol."},{"issue":"2","key":"B40-20260826","doi-asserted-by":"crossref","first-page":"F230","DOI":"10.1152\/ajprenal.00297.2017","article-title":"Lithium induces aerobic glycolysis and glutaminolysis in collecting duct principal cells","volume":"314","author":"Alsady","year":"2018","journal-title":"Am J Physiol Renal Physiol."},{"issue":"2","key":"B41-20260826","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1046\/j.1523-1755.2003.00096.x","article-title":"Lithium-induced nephropathy: rate of progression and prognostic factors","volume":"64","author":"Presne","year":"2003","journal-title":"Kidney Int."},{"key":"B42-20260826","doi-asserted-by":"crossref","first-page":"e939034","DOI":"10.12659\/AJCR.939034","article-title":"Central diabetes insipidus in the background of lithium use: consider central causes despite nephrogenic as the most common","volume":"24","author":"Li","year":"2022","journal-title":"Am J Case Rep."},{"issue":"6","key":"B43-20260826","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study","volume":"100","author":"Timper","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"B44-20260826","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"N Engl J Med."},{"issue":"1","key":"B45-20260826","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1017\/ipm.2019.9","article-title":"Managing polyuria during lithium treatment: a preliminary prospective observational study","volume":"39","author":"Kinahan","year":"2022","journal-title":"Ir J Psychol Med."},{"issue":"7","key":"B46-20260826","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJM198502143120705","article-title":"Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy","volume":"312","author":"Batlle","year":"1985","journal-title":"N Engl J Med."},{"issue":"17","key":"B47-20260826","doi-asserted-by":"crossref","first-page":"e70552","DOI":"10.14814\/phy2.70552","article-title":"Lithium-induced kidney injury and fibrosis: a versatile model to explore cellular pathways of injury and repair","volume":"13","author":"Mehta","year":"2025","journal-title":"Physiol Rep."},{"issue":"4","key":"B48-20260826","doi-asserted-by":"crossref","first-page":"F702","DOI":"10.1152\/ajprenal.00366.2007","article-title":"Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2","volume":"294","author":"Kim","year":"2008","journal-title":"Am J Physiol Renal Physiol."},{"key":"B49-20260826","doi-asserted-by":"crossref","first-page":"119542","DOI":"10.1016\/j.jad.2025.119542","article-title":"ENaC inhibitors for the management of lithium related polyuria: a systematic review","volume":"388","author":"Strawbridge","year":"2025","journal-title":"J Affective Disord."},{"issue":"1","key":"B50-20260826","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ki.2009.91","article-title":"Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus","volume":"76","author":"Kortenoeven","year":"2009","journal-title":"Kidney Int."},{"issue":"5","key":"B51-20260826","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.2215\/CJN.01640408","article-title":"Lithium-induced nephrogenic diabetes insipidus: renal effects of amiloride","volume":"3","author":"Bedford","year":"2008","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B52-20260826","doi-asserted-by":"crossref","first-page":"e2400063","DOI":"10.1002\/ardp.202400063","article-title":"Low exposition to lithium prevents nephrogenic diabetes insipidus but not microcystic dilations of the collecting ducts in long-term rat model","volume":"357","author":"Tabibzadeh","year":"2024","journal-title":"Archiv der Pharmazie."},{"issue":"7","key":"B53-20260826","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ajcn\/30.7.1070","article-title":"Role of diet in the management of vasopressin-responsive and -resistant diabetes insipidus","volume":"30","author":"Blalock","year":"1977","journal-title":"Am J Clin Nutr."},{"issue":"4","key":"B54-20260826","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1515\/jpem-2021-0566","article-title":"Nephrogenic diabetes insipidus: a comprehensive overview","volume":"35","author":"Vaz de Castro","year":"2022","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"5","key":"B55-20260826","doi-asserted-by":"crossref","first-page":"F525","DOI":"10.1152\/ajprenal.00617.2013","article-title":"Hydrochlorothiazide attenuates lithium-induced nephrogenic diabetes insipidus independently of the sodium-chloride cotransporter","volume":"306","author":"Sinke","year":"2014","journal-title":"Am J Physiol Renal Physiol."},{"key":"B56-20260826","first-page":"e943244","article-title":"Successful treatment of lithium-induced nephrogenic diabetes insipidus with celecoxib: a promising therapeutic option","volume":"25","author":"Hashikawa","year":"2024","journal-title":"Am J Case Rep."},{"issue":"10","key":"B57-20260826","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2169\/internalmedicine.2437-23","article-title":"Lithium-induced nephrogenic diabetes insipidus with efficacy of desmopressin in combination with thiazide diuretics and non-steroidal anti-inflammatory drugs: a case report with a review of the literature","volume":"63","author":"Jinnouchi","year":"2024","journal-title":"Intern Med."},{"issue":"12","key":"B58-20260826","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1056\/NEJM199103213241215","article-title":"Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP","volume":"324","author":"Stasior","year":"1991","journal-title":"N Engl J Med."},{"issue":"7","key":"B59-20260826","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1681\/ASN.2015070796","article-title":"Acetazolamide attenuates lithium-induced nephrogenic diabetes insipidus","volume":"27","author":"de Groot","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B60-20260826","doi-asserted-by":"crossref","first-page":"F669","DOI":"10.1152\/ajprenal.00147.2017","article-title":"Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability","volume":"313","author":"de Groot","year":"2017","journal-title":"Am J Physiol Renal Physiol."},{"issue":"8","key":"B61-20260826","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","article-title":"Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy","volume":"11","author":"Markowitz","year":"2000","journal-title":"J Am Soc Nephrol."},{"issue":"3","key":"B62-20260826","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/oxfordjournals.ndt.a027311","article-title":"Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study","volume":"11","author":"Bendz","year":"1996","journal-title":"Nephrol Dial Transplant."},{"issue":"10","key":"B63-20260826","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2215-0366(22)00265-6","article-title":"Kidney function in patients with bipolar disorder with and without lithium treatment compared with the general population in northern Sweden: results from the LiSIE and MONICA cohorts","volume":"9","author":"Fransson","year":"2022","journal-title":"Lancet Psychiatry."},{"key":"B64-20260826","doi-asserted-by":"crossref","first-page":"784298","DOI":"10.3389\/fphar.2021.784298","article-title":"Determinants of kidney function and accuracy of kidney microcysts detection in patients treated with lithium salts for bipolar disorder","volume":"12","author":"Tabibzadeh","year":"2022","journal-title":"Front Pharmacol."},{"issue":"3","key":"B65-20260826","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2013111216","article-title":"Lithium in kidney diseases: big roles for the smallest metal","volume":"25","author":"Livingston","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B66-20260826","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/npp.2015.254","article-title":"Stratifying risk for renal insufficiency among lithium-treated patients: an electronic health record study","volume":"41","author":"Castro","year":"2016","journal-title":"Neuropsychopharmacology."},{"issue":"5","key":"B67-20260826","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/MNH.0b013e32833d35cf","article-title":"Vasopressin beyond water: implications for renal diseases","volume":"19","author":"Bolignano","year":"2010","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"8","key":"B68-20260826","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/15622975.2024.2393373","article-title":"Lithium-associated hypercalcemia and hyperparathyroidism: a systematic review and meta-analysis","volume":"25","author":"Vandermeulen","year":"2024","journal-title":"World J Biol Psychiatry."},{"issue":"3","key":"B69-20260826","first-page":"386","article-title":"Incomplete syndrome of renal tubular acidosis induced by lithium carbonate","volume":"86","author":"Perez","year":"1975","journal-title":"J Lab Clin Med."},{"issue":"9","key":"B70-20260826","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1152\/physiolgenomics.00149.2020","article-title":"Genetic background determines renal response to chronic lithium treatment in female mice","volume":"53","author":"de Groot","year":"2021","journal-title":"Physiol Genomics."},{"issue":"9","key":"B71-20260826","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199409013310907","article-title":"Lithium in the treatment of mood disorders","volume":"331","author":"Price","year":"1994","journal-title":"N Engl J Med"},{"issue":"6","key":"B72-20260826","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41581-024-00823-3","article-title":"Drug stewardship in chronic kidney disease to achieve effective and safe medication use","volume":"20","author":"Hall","year":"2024","journal-title":"Nat Rev Nephrol."},{"issue":"6","key":"B73-20260826","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/bdi.13302","article-title":"Quality of laboratory biomarker monitoring during treatment with lithium in patients with bipolar disorder","volume":"25","author":"Bosi","year":"2023","journal-title":"Bipolar Disord."},{"issue":"5","key":"B74-20260826","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bdi.12730","article-title":"Compliance with the guidelines for laboratory monitoring of patients treated with lithium: a retrospective follow-up study among ambulatory patients in the Netherlands","volume":"21","author":"Nederlof","year":"2019","journal-title":"Bipolar Disord."},{"issue":"4","key":"B75-20260826","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/0269881118760663","article-title":"Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting","volume":"32","author":"Nikolova","year":"2018","journal-title":"J Psychopharmacol."},{"issue":"3","key":"B76-20260826","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/joim.20054","article-title":"Kidney function decline improves after lithium discontinuation","volume":"297","author":"Fransson","year":"2025","journal-title":"J Intern Med."},{"issue":"6","key":"B77-20260826","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bdi.13178","article-title":"Renal function after withdrawal of lithium","volume":"24","author":"Hoekstra","year":"2022","journal-title":"Bipolar Disord."},{"issue":"1","key":"B78-20260826","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12916-014-0249-4","article-title":"Renal function during long-term lithium treatment: a cross-sectional and longitudinal study","volume":"13","author":"Bocchetta","year":"2015","journal-title":"BMC Med."},{"issue":"7","key":"B79-20260826","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/bdi.13052","article-title":"Long-term lithium therapy and risk of chronic kidney disease in bipolar disorder: a historical cohort study","volume":"23","author":"Pahwa","year":"2021","journal-title":"Bipolar Disord."},{"issue":"7","key":"B80-20260826","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/bdi.13206","article-title":"Risk factors for early recurrence after discontinuing lithium in bipolar disorder","volume":"24","author":"Baldessarini","year":"2022","journal-title":"Bipolar Disord."},{"issue":"1","key":"B81-20260826","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/nep.12929","article-title":"Amiloride modifies the progression of lithium-induced renal interstitial fibrosis","volume":"23","author":"Kalita-De Croft","year":"2018","journal-title":"Nephrology (Carlton)."},{"issue":"1","key":"B82-20260826","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1017\/S1092852925100709","article-title":"Potential protective role of GLP-1 receptor agonists for lithium-induced nephrotoxicity: a population-based observational study","volume":"31","author":"McIntyre","year":"2025","journal-title":"CNS Spectr."},{"issue":"2","key":"B83-20260826","doi-asserted-by":"crossref","first-page":"e70094","DOI":"10.1111\/bdi.70094","article-title":"SGLT2 inhibitors associated with improved kidney function in lithium-treated patients with mood disorders: a real-world historical cohort study","volume":"28","author":"Ercis","year":"2026","journal-title":"Bipolar Disord."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:05:16Z","timestamp":1787745916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":83,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001172","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]}}}